PRESS RELEASE published on 01/23/2024 at 19:00, 1 year 10 months ago NFG Announces Strategic Investment Into Zodiac Partners Ltd. NFG Partners SA, a Geneva-based wealth and asset management firm, has made a strategic investment in Zodiac Partners Ltd., a UK-based securities broker and wealth manager. This collaboration aims to capitalize on the recent financial services trade deal between Switzerland and the UK, offering enriched product offerings and an enhanced client experience. The partnership marks a significant milestone for both companies and sets the stage for a synergistic alliance. Learn more about this strategic investment and its impact on the wealth management industry. Wealth Management Strategic Investment NFG Partners SA Zodiac Partners Ltd. Financial Services Trade Deal
PRESS RELEASE published on 06/22/2023 at 09:30, 2 years 5 months ago NFG Announces Its Subsidiary Company NFG Partners SA Has Successfully Obtained Its FINMA License
PRESS RELEASE published on 06/06/2023 at 09:15, 2 years 5 months ago NFG Announces AM Best Assignment of it’s Credit Rating to Newpoint Reinsurance Company Ltd.
Published on 12/05/2025 at 02:35, 1 hour 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 4 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 9 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 19 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 24 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 50 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 33 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
